New Research Shows siRNAs Suppress Blood, Lymphatic Vessel Growth Regardless of Sequence or Target

The data demonstrate that siRNAs that are 21 nucleotides in length or longer suppress both hemangiogenesis and lymphangiogenesis in vivo, regardless of their targets or sequences, due to the activation of TLR3.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories